Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Heart rate variation analysis may not effectively detect sleep apnoeas in heart failure

S. Teramoto, H. Kume, Y. Yamaguchi, H. Yamamoto, M. Ishii, T. Ishii, Y. Ouchi
European Respiratory Journal 2006 28: 457-458; DOI: 10.1183/09031936.06.00044106
S. Teramoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Kume
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Yamaguchi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Yamamoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Ishii
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Ishii
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Ouchi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

To the Editors:

In a recent issue of the European Respiratory Journal, Vazir et al. 1 demonstrated that spectral analysis of heart rate variations (HRV) may be useful as a “rule-out test” for sleep-disordered breathing (SDB) in patients with mild-to-moderate congestive heart failure (CHF). This is an interesting approach to the diagnosis of SDB in CHF patients without sleepiness. As CHF patients with Cheyne–Stokes respiration (CSR)/central sleep apnoea (CSA) are often asymptomatic, this noninvasive approach may be effective to rule out SDB in patients. However, we feel that there are a number of problems with the article by Vazir et al. 1.

First, HRV analysis cannot be applied in patients with arrhythmia, including atrial fibrillation (AF). In a group of patients with CHF, it has been demonstrated that there is a considerable association between AF and CSA 2. Thus, AF may be a feature of CHF with CSR/CSA. As AF is very common in CHF with CSR/CSA, it is difficult for HRV analysis alone to rule out the majority of patients with both AF and SDB. Furthermore, paroxysmal AF (PAF) can occur during the night in patients with sleep apnoea and in those of increased age 3. The presence of PAF episodes and frequent ventricular ectopy may impair the analysis of HRV in patients with CHF.

Secondly, there is the problem of the causal relationship between AF and CSR/CSA. It has been suggested that the risk factors for CSR/CSA are male sex, AF, aged >60 yrs and hypocapnia. AF may therefore be a causal factor for CSR/CSA. In this scenario, CHF patients with AF have a high risk for CSR/CSA. In addition, treatment of arrhythmia with atrial overdrive pacing (AOP) may also have some beneficial effects on sleep apnoea itself 4. Although obstructive sleep apnoea syndrome predisposes to clinically significant cardiac rhythm disturbances that can be successfully controlled by nasal continuous positive airway pressure, AOP has no significant effect on the respiratory variables, including the apnoea/hypopnoea index 5. Therefore, the causal relationships between AF and CSR/CSA are not simple.

Thirdly, CHF patients are often treated with antihypertensive agents. These agents also have some effect on HRV results. It has been reported that a sympathetic activation during the day and a decrease in parasympathetic activity during the night after therapy with a calcium channel blockade, amlodipine, correlated with increases in plasma noradrenaline (NA). In contrast, therapy with an angiotensin II receptor blocker, telmisartan, significantly increased parasympathetic activity without changes in NA during the night and day 6. It has also been suggested that treatment with a nonselective β-adrenergic blocking agent, carvedilol, in CHF restores both autonomic balance and the ability to increase reflex vagal activity 7. Thus, the treatment strategy for CHF with antihypertensive agents has a great impact on HRV analysis.

Autonomic disturbances and central nervous system abnormality also cause SDB and cardiac dysfunction 8. Patients with neurological disorders and CHF may not undergo HRV analysis.

The large number of CHF patients cannot all be examined in sleep laboratories, so alternative methods of screening for SDB may be required for CHF patients in AF. Although pulse oximetry may underestimate nondesaturated CSA, it still has an advantage over HRV monitoring in terms of convenient and widely available methods. Thus, CHF patients with negative results in SDB judged by pulse oximetry should be analysed with HRV.

In two previous studies 9, 10, sleep apnoea patients had markedly decreased heart rate variability and increased blood pressure variability. These variability abnormalities are characteristic of patients with hypertension. The abnormalities in cardiovascular variability may exaggerate ventricular function and contribute to development of AF and other cardiovascular diseases 9, 10. Although cardiovascular variability and HRV abnormality are features of CHF with SDB, the clinical significance of HRV analysis for screening SDB may be limited.

Because an ideal screening test should have a high sensitivity with a reasonable specificity, we believe that the conclusion drawn by Vazir et al. 1 should be changed to: “spectral analysis of heart rate variations may be useful as a noninvasive rule-out test for sleep-disordered breathing in patients with congestive heart failure without arrhythmia.”

    • © ERS Journals Ltd

    References

    1. ↵
      Vazir A, Dayer M, Hastings PC, et al. Can heart rate variation rule out sleep-disordered breathing in heart failure? Eur Respir J 2006;27:571–577.
      OpenUrlAbstract/FREE Full Text
    2. ↵
      Leung RS, Huber MA, Rogge T, Maimon N, Chiu KL, Bradley TD. Association between atrial fibrillation and central sleep apnea. Sleep 2005;28:1543–1546.
      OpenUrlPubMedWeb of Science
    3. ↵
      Schulz R, Eisele HJ, Seeger W. Nocturnal atrial fibrillation in a patient with obstructive sleep apnoea. Thorax 2005;60:174
      OpenUrlFREE Full Text
    4. ↵
      Garrigue S, Bordier P, Jais P, et al. Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 2002;346:404–412.
      OpenUrlCrossRefPubMedWeb of Science
    5. ↵
      Simantirakis EN, Schiza SE, Chrysostomakis SI, et al. Atrial overdrive pacing for the obstructive sleep apnea-hypopnea syndrome. N Engl J Med 2005;353:2568–2577.
      OpenUrlCrossRefPubMedWeb of Science
    6. ↵
      Karas M, Lacourciere Y, LeBlanc AR, et al. Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients. J Hypertens 2005;23:1251–1260.
      OpenUrlPubMedWeb of Science
    7. ↵
      Mortara A, La Rovere MT, Pinna GD, Maestri R, Capomolla S, Cobelli F. Reversal of deteriorated fractal behavior of heart rate variability by beta-blocker therapy in patients with advanced congestive heart failure. J Cardiovasc Electrophysiol 2001;12:26–32.
      OpenUrlCrossRefPubMedWeb of Science
    8. ↵
      Teramoto S, Ishii T, Matsuse T. Central sleep apnoeas in patients with Charcot-Marie-Tooth disease. Lancet 2001;358:70–71.
      OpenUrlPubMedWeb of Science
    9. ↵
      Teramoto S, Kume H, Matsuse T. Ambulatory blood pressure after sleep apnoea treatment. Lancet 2002;360:341
      OpenUrlPubMedWeb of Science
    10. ↵
      Teramoto S, Matsuse T, Ouchi Y. Does the altered cardiovascular variability in association with obstructive sleep apnea contribute to development of cardiovascular disease in patients with obstructive sleep apnea syndrome? Circulation 1999;100:e136–e137.
      OpenUrlFREE Full Text
    PreviousNext
    Back to top
    View this article with LENS
    Vol 28 Issue 2 Table of Contents
    European Respiratory Journal: 28 (2)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Heart rate variation analysis may not effectively detect sleep apnoeas in heart failure
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    Heart rate variation analysis may not effectively detect sleep apnoeas in heart failure
    S. Teramoto, H. Kume, Y. Yamaguchi, H. Yamamoto, M. Ishii, T. Ishii, Y. Ouchi
    European Respiratory Journal Aug 2006, 28 (2) 457-458; DOI: 10.1183/09031936.06.00044106

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Heart rate variation analysis may not effectively detect sleep apnoeas in heart failure
    S. Teramoto, H. Kume, Y. Yamaguchi, H. Yamamoto, M. Ishii, T. Ishii, Y. Ouchi
    European Respiratory Journal Aug 2006, 28 (2) 457-458; DOI: 10.1183/09031936.06.00044106
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • References
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Clinical outcomes of bronchiectasis in India
    • Reply: Clinical outcomes of bronchiectasis in India
    • Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Reviewers
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2023 by the European Respiratory Society